Showing results (61-70 of 91) with videos related to

Sort By:
Pageof 10
Tumori|June 25, 2020
Multiple primary malignancies involving lung cancer: a single-center experienceLuigi Ventura, Paolo Carbognani, Letizia Gnetti, et al.
Biochemical Pharmacology|June 29, 2024
Immunomodulatory effects of antiangiogenic tyrosine kinase inhibitors in renal cell carcinoma models: Impact on following anti-PD-1 treatmentsClaudia Fumarola, Silvia La Monica, Mara Bonelli, et al.
Immunotherapy|February 19, 2020
Optimizing PD-L1 evaluation on cytological samples from advanced non-small-cell lung cancerCecilia Bozzetti, Anna Squadrilli, Rita Nizzoli, et al.
Cancer Treatment and Research Communications|May 10, 2025
The prognostic value of the haemoglobin/red cell distribution width ratio in a cohort of pre-treated patients with renal cell carcinoma receiving nivolumabGiulia Claire Giudice, Sara Elena Rebuzzi, Giulia Mazzaschi, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 12, 2024
Unraveling the Molecular Landscape of Uterine Tumor Resembling Ovarian Sex Cord Tumor: Insights From A Clinicopathological, Morphologic, Immunohistochemical, and Molecular Analysis of 35 CasesMiroslava Flídrová, Nikola Hájková, Jan Hojný, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|April 9, 2020
Spatial architecture of tumour-infiltrating lymphocytes as a prognostic parameter in resected non-small-cell lung cancerGiovanni Bocchialini, Costanza Lagrasta, Denise Madeddu, et al.
The American Journal of Surgical Pathology|February 14, 2018
Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH) Syndrome and Carcinoid Tumors With/Without NECH: A Clinicopathologic, Radiologic, and Immunomolecular Comparison StudyMaria Cecilia Mengoli, Giulio Rossi, Alberto Cavazza, et al.
BMC Cancer|May 4, 2015
Proteoglycan-based diversification of disease outcome in head and neck cancer patients identifies NG2/CSPG4 and syndecan-2 as unique relapse and overall survival predicting factorsAnna Farnedi, Silvia Rossi, Nicoletta Bertani, et al.
Archivos De Bronconeumologia|April 9, 2023
Relationship Between the Diffusing Capacity of the Lung for Carbon Monoxide (DLCO) and Lung Adenocarcinoma Patterns: New Possible InsightsLuigi Ventura, Letizia Gnetti, Gianluca Milanese, et al.
Exploration of Targeted Anti-Tumor Therapy|September 18, 2023
Retrospective immunophenotypical evaluation of MET, PD-1/PD-L1, and mTOR pathways in primary tumors and pulmonary metastases of renal cell carcinoma: the RIVELATOR study addresses the issue of biomarkers heterogeneityMelissa Bersanelli, Letizia Gnetti, Francesco Paolo Pilato, et al.
Pageof 10